2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]acetic acid;2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[(2S)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]ethanone;(3S)-1-(4-chlorophenyl)-3-methylpiperazine;methane;tetrahydrochloride
C43H54Cl6N18O3 — CID 158082104
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]acetic acid;2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[(2S)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]ethanone;(3S)-1-(4-chlorophenyl)-3-methylpiperazine;methane;tetrahydrochloride
2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]acetic acid;2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[(2S)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]ethanone;(3S)-1-(4-chlorophenyl)-3-methylpiperazine;methane;tetrahydrochloride (PubChem CID 158082104) has the molecular formula C43H54Cl6N18O3 and a molecular weight of 1083.75 g/mol. Its IUPAC name is 2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]acetic acid;2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[(2S)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]ethanone;(3S)-1-(4-chlorophenyl)-3-methylpiperazine;methane;tetrahydrochloride.
Molecular Properties
| Compound Name | 2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]acetic acid;2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[(2S)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]ethanone;(3S)-1-(4-chlorophenyl)-3-methylpiperazine;methane;tetrahydrochloride |
|---|---|
| PubChem CID | 158082104 |
| Molecular Formula | C43H54Cl6N18O3 |
| Molecular Weight | 1083.75 g/mol |
| Exact Mass | 1080.28 |
| IUPAC Name | 2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]acetic acid;2-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[(2S)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]ethanone;(3S)-1-(4-chlorophenyl)-3-methylpiperazine;methane;tetrahydrochloride |
| SMILES | C.C[C@H]1CN(c2ccc(Cl)cc2)CCN1.C[C@H]1CN(c2ccc(Cl)cc2)CCN1C(=O)Cn1nc(-c2ncc[nH]2)c2c(N)ncnc21.Cl.Cl.Cl.Cl.Nc1ncnc2c1c(-c1ncc[nH]1)nn2CC(=O)O |
| InChI | InChI=1S/C21H22ClN9O.C11H15ClN2.C10H9N7O2.CH4.4ClH/c1-13-10-29(15-4-2-14(22)3-5-15)8-9-30(13)16(32)11-31-21-17(19(23)26-12-27-21)18(28-31)20-24-6-7-25-20;1-9-8-14(7-6-13-9)11-4-2-10(12)3-5-11;11-8-6-7(9-12-1-2-13-9)16-17(3-5(18)19)10(6)15-4-14-8;;;;;/h2-7,12-13H,8-11H2,1H3,(H,24,25)(H2,23,26,27);2-5,9,13H,6-8H2,1H3;1-2,4H,3H2,(H,12,13)(H,18,19)(H2,11,14,15);1H4;4*1H/t13-;9-;;;;;;/m00....../s1 |
| InChIKey | NTIZEJHMVQDZSL-XOJOUIOLSA-N |
| XLogP | 6.53 |
| TPSA | 272.72 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 70 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1083.75 |
| LogP ≤ 5 | 6.53 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158082104 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.